TR200401811T4 - Antitümör ve antianjiyogenetik etkinlikleri olan yarı-sentetik taksanlar. - Google Patents

Antitümör ve antianjiyogenetik etkinlikleri olan yarı-sentetik taksanlar.

Info

Publication number
TR200401811T4
TR200401811T4 TR2004/01811T TR200401811T TR200401811T4 TR 200401811 T4 TR200401811 T4 TR 200401811T4 TR 2004/01811 T TR2004/01811 T TR 2004/01811T TR 200401811 T TR200401811 T TR 200401811T TR 200401811 T4 TR200401811 T4 TR 200401811T4
Authority
TR
Turkey
Prior art keywords
antiangiogenetic
antitumor
activities
semi
taxanes
Prior art date
Application number
TR2004/01811T
Other languages
English (en)
Inventor
Bombardelli Ez�O
Pontiroli Alessandro
Original Assignee
Indena S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A filed Critical Indena S.P.A
Publication of TR200401811T4 publication Critical patent/TR200401811T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bakatin III'ün oksidasyonu, stereospesifik indirgenmesi ve esterifikasyonu ile elde edilen yeni türevler ve bu türevlerin antitümör, antianjiyogenetik ve anti-artroz maddeleri olarak kullanimi anlatilmistir. Bulusun bilesikleri, diger taksanlarin sitotoksikligi ile karsilastirilabilir sitotoksiklige sahipse de, daha düsük sistemik toksiklige sahiptirler ve damardan ya da agizdan tatbik edilebilmektedirler.
TR2004/01811T 2000-01-18 2001-01-15 Antitümör ve antianjiyogenetik etkinlikleri olan yarı-sentetik taksanlar. TR200401811T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000056A IT1317731B1 (it) 2000-01-18 2000-01-18 Tassani semisintetici con attivita' antitumorale ed antiangiogenetica.

Publications (1)

Publication Number Publication Date
TR200401811T4 true TR200401811T4 (tr) 2004-09-21

Family

ID=11443708

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01811T TR200401811T4 (tr) 2000-01-18 2001-01-15 Antitümör ve antianjiyogenetik etkinlikleri olan yarı-sentetik taksanlar.

Country Status (24)

Country Link
US (2) US6589979B2 (tr)
EP (1) EP1248776B1 (tr)
JP (1) JP4986354B2 (tr)
KR (1) KR100813704B1 (tr)
CN (1) CN1176916C (tr)
AT (1) ATE271044T1 (tr)
AU (1) AU781650B2 (tr)
CA (1) CA2397591C (tr)
CZ (1) CZ301251B6 (tr)
DE (1) DE60104281T2 (tr)
DK (1) DK1248776T3 (tr)
ES (1) ES2223778T3 (tr)
HK (1) HK1049998B (tr)
HU (1) HU229347B1 (tr)
IL (1) IL150787A0 (tr)
IT (1) IT1317731B1 (tr)
NO (1) NO329403B1 (tr)
PL (1) PL202591B1 (tr)
PT (1) PT1248776E (tr)
RU (1) RU2259363C2 (tr)
SI (1) SI1248776T1 (tr)
SK (1) SK285683B6 (tr)
TR (1) TR200401811T4 (tr)
WO (1) WO2001053282A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688415A1 (en) * 2004-12-07 2006-08-09 Aventis Pharma S.A. Cytotoxic agents comprising new C-2 modified taxanes
ITMI20050415A1 (it) * 2005-03-15 2006-09-16 Indena Spa Derivati tassanici semi-sintetici ad attivita' antitumorale
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220150408A (ko) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
DE69507702T2 (de) * 1994-07-26 1999-08-26 Indena S.P.A. Semisynthetisch taxal derivate mit antitumor wirkung

Also Published As

Publication number Publication date
DE60104281D1 (de) 2004-08-19
DK1248776T3 (da) 2004-11-22
SK10562002A3 (sk) 2002-11-06
HUP0204344A2 (en) 2003-05-28
KR20020068082A (ko) 2002-08-24
CZ301251B6 (cs) 2009-12-23
RU2002119060A (ru) 2004-01-10
CA2397591A1 (en) 2001-07-26
CN1176916C (zh) 2004-11-24
KR100813704B1 (ko) 2008-03-13
JP4986354B2 (ja) 2012-07-25
NO329403B1 (no) 2010-10-11
JP2003520792A (ja) 2003-07-08
US20030028038A1 (en) 2003-02-06
HK1049998B (zh) 2005-04-01
ATE271044T1 (de) 2004-07-15
CA2397591C (en) 2009-10-20
IT1317731B1 (it) 2003-07-15
HUP0204344A3 (en) 2004-01-28
AU3369401A (en) 2001-07-31
ITMI20000056A1 (it) 2001-07-18
US6589979B2 (en) 2003-07-08
WO2001053282A1 (en) 2001-07-26
AU781650B2 (en) 2005-06-02
EP1248776A1 (en) 2002-10-16
NO20023428D0 (no) 2002-07-17
CZ20022478A3 (cs) 2002-10-16
DE60104281T2 (de) 2005-08-18
RU2259363C2 (ru) 2005-08-27
EP1248776B1 (en) 2004-07-14
PL202591B1 (pl) 2009-07-31
CN1395571A (zh) 2003-02-05
SI1248776T1 (en) 2004-10-31
NO20023428L (no) 2002-09-16
ITMI20000056A0 (it) 2000-01-18
USRE39723E1 (en) 2007-07-10
HU229347B1 (hu) 2013-11-28
IL150787A0 (en) 2003-02-12
PT1248776E (pt) 2004-10-29
PL356272A1 (en) 2004-06-28
ES2223778T3 (es) 2005-03-01
HK1049998A1 (en) 2003-06-06
SK285683B6 (sk) 2007-06-07

Similar Documents

Publication Publication Date Title
IL130669A0 (en) Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
BG105967A (en) C(7) ester substituted taxanes and their use as antitumor agents
ATE314383T1 (de) 2-amino-propanol derivate
BRPI0717266A2 (pt) Derivados de oxindol
TR201909741T4 (tr) Kolon temizleme bileşimleri.
AU2795000A (en) Epothilone derivatives and their use as antitumor agents
ATE297901T1 (de) Kondensierte imidazolderivate
ATE176464T1 (de) Semisynthetisch taxal derivate mit antitumor wirkung
TR200401811T4 (tr) Antitümör ve antianjiyogenetik etkinlikleri olan yarı-sentetik taksanlar.
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
RU95116366A (ru) Способ получения таксановых производных и бета -лактамные промежуточные соединения для них
BRPI0506477A (pt) compostos farmaceuticamente úteis e inovadores
ATE146179T1 (de) 27 hydroxyrapamycin und derivate davon
SE9801494D0 (sv) Novel use
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
ATE259813T1 (de) Triazolopyrimidinderivate
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
ATE269315T1 (de) C10 taxan derivate und pharmazeutische zusammensetzungen
ID23900A (id) Turunan-turunan dolastatin-15 dalam kombinasi dengan taksana
AU7078301A (en) Variolin derivatives as anti-cancer agents
NO20014760D0 (no) C(10)-karbamoyloksysubstituerte taksaner som antitumormidler
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
DE60138853D1 (de) C10-taxanester als antitumormittel
ATE336244T1 (de) Metallorganisches antitumormittel
TNSN07300A1 (en) 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents